Norges Bank Takes Position in Sotera Health (NASDAQ:SHC)

Norges Bank acquired a new stake in Sotera Health (NASDAQ:SHC - Free Report) during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 933,069 shares of the company's stock, valued at approximately $12,764,000. Norges Bank owned 0.33% of Sotera Health as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors also recently added to or reduced their stakes in the business. Geode Capital Management LLC increased its position in shares of Sotera Health by 19.4% during the third quarter. Geode Capital Management LLC now owns 2,755,391 shares of the company's stock worth $46,026,000 after acquiring an additional 447,186 shares during the last quarter. Neo Ivy Capital Management acquired a new position in shares of Sotera Health during the third quarter valued at approximately $720,000. Barclays PLC increased its holdings in shares of Sotera Health by 169.8% in the third quarter. Barclays PLC now owns 473,597 shares of the company's stock valued at $7,909,000 after buying an additional 298,085 shares in the last quarter. SG Americas Securities LLC lifted its position in shares of Sotera Health by 271.6% during the 4th quarter. SG Americas Securities LLC now owns 36,364 shares of the company's stock valued at $497,000 after acquiring an additional 26,577 shares during the last quarter. Finally, KBC Group NV grew its holdings in shares of Sotera Health by 4,094.6% in the 4th quarter. KBC Group NV now owns 186,365 shares of the company's stock worth $2,549,000 after acquiring an additional 181,922 shares during the last quarter. Hedge funds and other institutional investors own 91.03% of the company's stock.

Sotera Health Stock Performance

SHC traded down $0.09 during trading hours on Friday, reaching $10.51. The company's stock had a trading volume of 1,456,650 shares, compared to its average volume of 1,197,216. The company has a debt-to-equity ratio of 4.91, a quick ratio of 2.61 and a current ratio of 2.88. The company's 50-day moving average is $12.15 and its 200-day moving average is $13.52. Sotera Health has a 52 week low of $9.53 and a 52 week high of $17.08. The firm has a market cap of $2.98 billion, a PE ratio of 42.04 and a beta of 1.88.

Wall Street Analysts Forecast Growth

Separately, Barclays decreased their price target on shares of Sotera Health from $16.00 to $12.00 and set an "overweight" rating for the company in a report on Thursday. Two research analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. Based on data from MarketBeat.com, Sotera Health has an average rating of "Moderate Buy" and an average price target of $15.20.

Sotera Health Company Profile

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.